DNA topoisomerases as targets for cancer therapy
- 15 December 1985
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (24) , 4191-4195
- https://doi.org/10.1016/0006-2952(85)90273-4
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatinCell, 1985
- Virus- and cell-encoded tyrosine protein kinases inactivate DNA topoisomerases in vitroNature, 1984
- DNA topoisomerase activities in concanavalin A‐stimulated lymphocytesFEBS Letters, 1984
- Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26Biochemical and Biophysical Research Communications, 1984
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984
- Epidermal growth factor-induced topoisomerase(s)Experimental Cell Research, 1983
- The nature of DNA breakage by 4'-[(9-acridinyl)amino]methane-sulphon-m -anisidideFEBS Letters, 1982
- DNA-repair deficiencies do not affect intercalator-induced cytotoxicity or DNA scission in human cellsMutation Research Letters, 1982
- Continuous induction of chromatid lesions by DNA-intercalating compoundsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1975
- Degree of superhelicity of covalently closed cyclic DNA's from Escherichia coliJournal of Molecular Biology, 1969